Use and clinical implications of anticoagulation maintenance after a successful cardioversion;Uso e implicaciones clínicas del mantenimiento de la anticoagulación tras una cardioversión eficaz

Medicina Clinica

Volumn 137, Issue 1, 2011, Pages 14-16

  Alegret, Josep M ^a   Viñolas, Xavier ^b   Villacastín, Julián ^c   Martínez, Juan G ^d   Pachón, Nicolás ^e   Crespo, Francisco ^f  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL XERAL CALDE   (Spain)

Author keywords

Anticoagulation; Atrial fibrillation; Cardioversion

Indexed keywords

ANTICOAGULANT AGENT;

ANTICOAGULATION; ARTICLE; CARDIOVERSION; EMBOLISM; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; SINUS RHYTHM;

ANTICOAGULANTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; EMBOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; REMISSION INDUCTION;

EID: 79958022698     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.09.007     Document Type: Article

References (10)

1. V. Fuster, L.E. Rydén, D.S. Cannom, H.J. Crijns, A.B. Curtis, and K.A. Ellenbogen ACC/AHA/ESC: Guía de práctica clínica 2006 para el uso de pacientes con fibrilación auricular.Versión resumida Rev Esp Cardiol. 59 2006 1329
2. D.G. Wyse, A.L. Waldo, J.P. DiMarco, M.J. Domanski, Y. Rosenberg, and E.B. Schron Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med. 347 2002 1825 1833
3. J.M. Alegret, X. Viñolas, J. Sagristá, A. Hernández-Madrid, A. Berruezo, and A. Moya Clinical characteristics of patients with persistent atrial fibrillation referred for cardioversion: Spanish Cardioversion Registry Rev Esp Cardiol. 61 2008 630 634 (Pubitemid 351930573)
4. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA. 285 2001 2864 2870 (Pubitemid 32537350)
5. C.J. Bjerkelund, and O.M. Orning The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation Am J Cardiol. 23 1969 208 216
6. K. Harjai, S. Mobarek, F. Abi-Samra, Y. Gilliland, N. Davison, and K. Drake Mechanical dysfunction of the left atrium and the left atrial appendage following cardioversion of atrial fibrillation and its relation to total electrical energy used for cardioversion Am J Cardiol. 81 1998 1125 1129 (Pubitemid 28232684)
7. S.J. Connolly, A. Laupacis, M. Gent, R.S. Roberts, J.A. Cairns, and C. Joyner Canadian Atrial Fibrillation Anticoagulation (CAFA) Study J Am Coll Cardiol. 18 1991 349 355
8. The Stroke Prevention in Atrial Fibrillation Investigators The Stroke Prevention in Atrial Fibrillation Investigators. Bleeding during antithrombotic therapy in patients with atrial fibrillation Arch Intern Med. 156 1996 409 416
9. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation. 115 2007 2689 2696 (Pubitemid 46842784)
10. E. Oliva Berini, P. Galán Alvarez, and A.M. Pacheco Onrubia Comparación de la calidad y el riesgo hemorrágico del tratamiento anticoagulante oral con acenocumarol frente a warfarina Med Clin (Barc). 131 2008 96 97 (Pubitemid 351930543)